Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Gross Profit (2020 - 2025)

RxSight (RXST) has disclosed Gross Profit for 6 consecutive years, with $25.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit fell 12.24% year-over-year to $25.3 million, compared with a TTM value of $103.0 million through Dec 2025, up 4.11%, and an annual FY2025 reading of $103.0 million, up 4.11% over the prior year.
  • Gross Profit was $25.3 million for Q4 2025 at RxSight, up from $24.2 million in the prior quarter.
  • Across five years, Gross Profit topped out at $28.8 million in Q4 2024 and bottomed at -$812000.0 in Q2 2021.
  • Average Gross Profit over 5 years is $14.1 million, with a median of $12.9 million recorded in 2023.
  • The sharpest move saw Gross Profit soared 689.66% in 2022, then decreased 12.24% in 2025.
  • Year by year, Gross Profit stood at $2.9 million in 2021, then surged by 158.7% to $7.4 million in 2022, then soared by 137.86% to $17.7 million in 2023, then skyrocketed by 63.07% to $28.8 million in 2024, then fell by 12.24% to $25.3 million in 2025.
  • Business Quant data shows Gross Profit for RXST at $25.3 million in Q4 2025, $24.2 million in Q3 2025, and $25.2 million in Q2 2025.